In this issue:
On-treatment BP and cardiovascular outcomes in high-risk patients
Optimal on-treatment SBP targets: a meta-analysis
Adverse events reported with unblinded vs blinded statin therapy
Long-term efficacy and safety of evolocumab in hypercholesterolaemia
Primary prevention ICDs in non-ischaemic cardiomyopathy
Vitamin D supplementation and cardiovascular disease
Impact of trans-fatty acid restrictions in New York state
Coronary calcium score predicts cardiovascular risk
Use of prasugrel in ACS patients undergoing PCI
Please login below to download this issue (PDF)